Issued 2026-09-16 at $18.52 · now $18.52 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, FRBT has typically landed between $17.11 and $20.77 — a range of −7.6% to +12.1% from the issuance price $18.52.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
46 overlapping 1 month windows · 2026-06-11 – 2026-08-17 · basis climatology · forecast (batch).
The cone is anchored at the 2026-09-16 issuance close ($18.52) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where FRBT has typically landed a month from the 2026-09-16 close of $18.52 — the range is history, not a prediction.
- now $18.52 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $18.28 (-1.3%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $17.34–$19.22
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $17.11–$20.77
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2026-08-03 | −9.6% | −9.6% | +0.0% |
| 2026-07-31 | −7.7% | −7.7% | +0.4% |
| 2026-07-28 | −6.8% | −6.8% | +0.0% |
| 3 best | |||
| 2026-06-11 | +11.0% | −0.6% | +11.7% |
| 2026-06-26 | +9.2% | +0.0% | +11.2% |
| 2026-06-18 | +9.1% | +0.0% | +12.3% |
46 overlapping windows · 2026-06-11 – 2026-09-16 · not cherry-picked
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
18 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-14 | Sachs Lewis A | director | Disposition | 1,095,351 | 7,744,751 | Form 4 |
| 2026-08-14 | Sachs Lewis A | director | Award / grant | 1,095,351 | 3,178,251 | Form 4 |
| 2026-08-14 | Sachs Lewis A | director | Disposition | 1,095,351 | 7,744,751 | Form 4 |
| 2026-08-14 | Sachs Lewis A | director | Award / grant | 1,095,351 | 3,178,251 | Form 4 |
| 2026-08-14 | Sachs Lewis A | director | Disposition | 1,095,351 | 7,744,751 | Form 4 |
| 2026-08-14 | Sachs Lewis A | director | Award / grant | 1,095,351 | 3,178,251 | Form 4 |
| 2026-08-14 | Sachs Lewis A | director | Disposition | 1,095,351 | 7,744,751 | Form 4 |
| 2026-08-14 | Sachs Lewis A | director | Award / grant | 1,095,351 | 3,178,251 | Form 4 |
| 2026-08-07 | Lynch Christopher Spencer | officer | Withheld for tax | 4,915 | 98,688 | Form 4 |
| 2026-07-16 | Shafran Steven M | director | Award / grant | 235 | 6,441 | Form 4 |
| 2026-07-16 | Flanders Cynthia | director | Award / grant | 220 | 20,241 | Form 4 |
| 2026-07-16 | FISH JASON M | director | Award / grant | 205 | 6,376 | Form 4 |
| 2026-06-10 | Kohn Donald | director | Award / grant | 6,171 | 6,206 | Form 4 |
| 2026-06-10 | Eberhardt Nancy K | director | Award / grant | 6,171 | 6,171 | Form 4 |
| 2026-06-10 | Shafran Steven M | director | Award / grant | 6,171 | 6,206 | Form 4 |
| 2026-06-10 | FISH JASON M | director | Award / grant | 6,171 | 6,171 | Form 4 |
| 2026-06-10 | Flanders Cynthia | director | Award / grant | 6,171 | 20,021 | Form 4 |
| 2026-06-10 | Jones Christopher Travis | director | Award / grant | 6,171 | 6,171 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.